Cargando…
Cancer and liver cirrhosis: implications on prognosis and management
Liver cirrhosis, the end-stage of every chronic liver disease, is not only the major risk factor for the development of hepatocellular carcinoma but also a limiting factor for anticancer therapy of liver and non-hepatic malignancies. Liver cirrhosis may limit surgical and interventional approaches t...
Autores principales: | Pinter, Matthias, Trauner, Michael, Peck-Radosavljevic, Markus, Sieghart, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070280/ https://www.ncbi.nlm.nih.gov/pubmed/27843598 http://dx.doi.org/10.1136/esmoopen-2016-000042 |
Ejemplares similares
-
The impact of thyroid hormones on patients with hepatocellular carcinoma
por: Pinter, Matthias, et al.
Publicado: (2017) -
Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib
por: Rohr-Udilova, Nataliya, et al.
Publicado: (2017) -
Short- and long-term effects of transarterial chemoembolization on
portal hypertension in patients with hepatocellular carcinoma
por: Scheiner, Bernhard, et al.
Publicado: (2019) -
Review article: systemic treatment of hepatocellular carcinoma
por: Pinter, Matthias, et al.
Publicado: (2018) -
Proton Pump Inhibitor Intake neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites
por: Mandorfer, Mattias, et al.
Publicado: (2014)